scholarly journals Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

2012 ◽  
Vol 106 (9) ◽  
pp. 1571-1578 ◽  
Author(s):  
E A Burger ◽  
J D Ortendahl ◽  
S Sy ◽  
I S Kristiansen ◽  
J J Kim
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Cost Effectiveness ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Human Papillomavirus Testing

scholarly journals Cost-effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in Québec, Canada

2010 ◽  
Vol 101 (3) ◽  
pp. 220-225 ◽  
Author(s):  
Arthi Vijayaraghavan ◽  
Molly B. Efrusy ◽  
Marie-Hélène Mayrand ◽  
Christopher C. Santas ◽  
Patricia Goggin
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Cost Effectiveness ◽  
Cancer Screening ◽  
High Risk ◽  
Cervical Cancer Screening ◽  
Human Papillomavirus Testing

Laboratory Implementation of Human Papillomavirus Testing

2003 ◽  
Vol 127 (8) ◽  
pp. 984-990
Author(s):  
David R. Bolick
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Market Forces ◽  
Economic Issues ◽  
Testing Service ◽  
Human Papillomavirus Testing ◽  
Integral Component ◽  
Best Fit

Abstract Human papillomavirus testing is becoming an integral component of cervical cancer screening. Market forces will require most laboratories that perform Papanicolaou tests to develop a system for handling human papillomavirus testing also. Data and information are presented that may facilitate laboratories when addressing the following issues in the process of developing a human papillomavirus testing service: Which methodology is the best fit for the laboratory? Is it better to develop an in-house testing service or to send it out? How do I get started? What are the financial and economic issues, and how should they be managed?

Sign in / Sign up

Export Citation Format

Share Document